BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 22738085)

  • 1. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.
    Perner A; Haase N; Guttormsen AB; Tenhunen J; Klemenzson G; Åneman A; Madsen KR; Møller MH; Elkjær JM; Poulsen LM; Bendtsen A; Winding R; Steensen M; Berezowicz P; Søe-Jensen P; Bestle M; Strand K; Wiis J; White JO; Thornberg KJ; Quist L; Nielsen J; Andersen LH; Holst LB; Thormar K; Kjældgaard AL; Fabritius ML; Mondrup F; Pott FC; Møller TP; Winkel P; Wetterslev J; ;
    N Engl J Med; 2012 Jul; 367(2):124-34. PubMed ID: 22738085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyethyl starch in severe sepsis: end of starch era?
    Estrada CA; Murugan R
    Crit Care; 2013 Mar; 17(2):310. PubMed ID: 23509901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyethyl starch in sepsis.
    Haase NR
    Dan Med J; 2014 Jan; 61(1):B4764. PubMed ID: 24393593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate.
    Perner A; Haase N; Winkel P; Guttormsen AB; Tenhunen J; Klemenzson G; Müller RG; Aneman A; Wetterslev J
    Intensive Care Med; 2014 Jul; 40(7):927-34. PubMed ID: 24807084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial.
    Perner A; Haase N; Wetterslev J; Aneman A; Tenhunen J; Guttormsen AB; Klemenzson G; Pott F; Bødker KD; Bådstøløkken PM; Bendtsen A; Søe-Jensen P; Tousi H; Bestle M; Pawlowicz M; Winding R; Bülow HH; Kancir C; Steensen M; Nielsen J; Fogh B; Madsen KR; Larsen NH; Carlsson M; Wiis J; Petersen JA; Iversen S; Schøidt O; Leivdal S; Berezowicz P; Pettilä V; Ruokonen E; Klepstad P; Karlsson S; Kaukonen M; Rutanen J; Karason S; Kjældgaard AL; Holst LB; Wernerman J;
    Trials; 2011 Jan; 12():24. PubMed ID: 21269526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double-blind clinical trial.
    Béchir M; Puhan MA; Fasshauer M; Schuepbach RA; Stocker R; Neff TA
    Crit Care; 2013 Dec; 17(6):R299. PubMed ID: 24365167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis.
    Anthon CT; Müller RB; Haase N; Hjortrup PB; Møller K; Lange T; Wetterslev J; Perner A
    Acta Anaesthesiol Scand; 2017 Sep; 61(8):904-913. PubMed ID: 28653377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.
    Müller RB; Haase N; Lange T; Wetterslev J; Perner A
    Acta Anaesthesiol Scand; 2015 Mar; 59(3):329-36. PubMed ID: 25524831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial.
    Haase N; Wetterslev J; Winkel P; Perner A
    Intensive Care Med; 2013 Dec; 39(12):2126-34. PubMed ID: 24081433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
    Brunkhorst FM; Engel C; Bloos F; Meier-Hellmann A; Ragaller M; Weiler N; Moerer O; Gruendling M; Oppert M; Grond S; Olthoff D; Jaschinski U; John S; Rossaint R; Welte T; Schaefer M; Kern P; Kuhnt E; Kiehntopf M; Hartog C; Natanson C; Loeffler M; Reinhart K;
    N Engl J Med; 2008 Jan; 358(2):125-39. PubMed ID: 18184958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
    Bagshaw SM; Chawla LS
    Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystalloids vs. colloids: KO at the twelfth round?
    Phillips DP; Kaynar AM; Kellum JA; Gomez H
    Crit Care; 2013 May; 17(3):319. PubMed ID: 23731998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyethyl starch or saline for fluid resuscitation in intensive care.
    Myburgh JA; Finfer S; Bellomo R; Billot L; Cass A; Gattas D; Glass P; Lipman J; Liu B; McArthur C; McGuinness S; Rajbhandari D; Taylor CB; Webb SA; ;
    N Engl J Med; 2012 Nov; 367(20):1901-11. PubMed ID: 23075127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial.
    Wittbrodt P; Haase N; Butowska D; Winding R; Poulsen JB; Perner A; ;
    Crit Care; 2013 Feb; 17(2):R58. PubMed ID: 23531324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature.
    Serpa Neto A; Veelo DP; Peireira VG; de Assunção MS; Manetta JA; Espósito DC; Schultz MJ
    J Crit Care; 2014 Feb; 29(1):185.e1-7. PubMed ID: 24262273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three fluid solutions for resuscitation in dengue shock syndrome.
    Wills BA; Nguyen MD; Ha TL; Dong TH; Tran TN; Le TT; Tran VD; Nguyen TH; Nguyen VC; Stepniewska K; White NJ; Farrar JJ
    N Engl J Med; 2005 Sep; 353(9):877-89. PubMed ID: 16135832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Hospital and Patient Characteristics with Fluid Resuscitation Volumes in Patients with Severe Sepsis: Post Hoc Analyses of Data from a Multicentre Randomised Clinical Trial.
    Hjortrup PB; Haase N; Wetterslev J; Perner A
    PLoS One; 2016; 11(5):e0155767. PubMed ID: 27196104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetate Ringer's solution versus 0.9% saline for septic patients: study protocol for a multi-center parallel controlled trial.
    Liu F; Zhang J; Zhu Y; Su L; Li Y; He L; Yu L; Peng Z
    Trials; 2021 Jan; 22(1):89. PubMed ID: 33494795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial.
    Müller RG; Haase N; Wetterslev J; Perner A
    Intensive Care Med; 2013 Nov; 39(11):1963-71. PubMed ID: 24037226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboelastography in patients with severe sepsis: a prospective cohort study.
    Haase N; Ostrowski SR; Wetterslev J; Lange T; Møller MH; Tousi H; Steensen M; Pott F; Søe-Jensen P; Nielsen J; Hjortrup PB; Johansson PI; Perner A
    Intensive Care Med; 2015 Jan; 41(1):77-85. PubMed ID: 25413378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.